A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

被引:459
作者
Marin, MC
Jost, CA
Brooks, LA
Irwin, MS
O'Nions, J
Tidy, JA
James, N
McGregor, JM
Harwood, CA
Yulug, IG
Vousden, KH
Allday, MJ
Gusterson, B
Ikawa, S
Hinds, PW
Crook, T
Kaelin, WG [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] London Sch Hyg & Trop Med, London WC1, England
[4] Inst Canc Res, Sect Cell Biol & Expt Pathol, London SW3 6JB, England
[5] Univ Sheffield, No Gen Hosp, Dept Gynecol Oncol, Sheffield S5 7AU, S Yorkshire, England
[6] Univ Birmingham, CRC, Inst Canc Studies, Birmingham, W Midlands, England
[7] Ctr Cutaneous Res, London, England
[8] NCI, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
[9] St Marys Hosp, Imperial Coll Sci Technol & Med, Ludwig Inst Canc Res, London, England
[10] Tohoku Univ, Inst Dev Aging & Canc, Dept Cell Biol, Sendai, Miyagi 980, Japan
[11] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA
[12] Howard Hughes Med Inst, Coconut Grove, FL 33133 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/75586
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The p73 protein, a homologue of the tumour-suppressor protein p53, can activate p53-responsive promoters and induce apoptosis in p53-deficient cells. Here we report that some tumour-derived p53 mutants can bind to and inactivate p73. The binding of such mutants is influenced by whether TP53 (encoding p53) codon 72, by virtue of a common polymorphism in the human population, encodes Arg or Pro. The ability of mutant p53 to bind p73, neutralize p73-induced apoptosis and transform cells in cooperation with EJ-Ras was enhanced when codon 72 encoded Arg. We found that the Arg-containing allele was preferentially mutated and retained in squamous cell tumours arising in Arg/Pro germline heterozygotes. Thus, inactivation of p53 family members may contribute to the biological properties of a subset of p53 mutants, and a polymorphic residue within p53 affects mutant behaviour.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 49 条
[41]  
SHAULSKY G, 1991, CANCER RES, V51, P5232
[42]  
Storey A, 1998, NATURE, V396, P532, DOI 10.1038/25043
[43]   FUNCTIONAL DOMAINS OF WILD-TYPE AND MUTANT P53 PROTEINS INVOLVED IN TRANSCRIPTIONAL REGULATION, TRANSDOMINANT INHIBITION, AND TRANSFORMATION SUPPRESSION [J].
UNGER, T ;
MIETZ, JA ;
SCHEFFNER, M ;
YEE, CL ;
HOWLEY, PM .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (09) :5186-5194
[44]   Identification of a novel p53 functional domain that is necessary for efficient growth suppression [J].
Walker, KK ;
Levine, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) :15335-15340
[45]   DETERMINATION OF THE ALLELIC FREQUENCIES OF AN L-MYC AND A P53 POLYMORPHISM IN HUMAN LUNG-CANCER [J].
WESTON, A ;
LINGCAWLEY, HM ;
CAPORASO, NE ;
BOWMAN, ED ;
HOOVER, RN ;
TRUMP, BF ;
HARRIS, CC .
CARCINOGENESIS, 1994, 15 (04) :583-587
[46]   p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development [J].
Yang, A ;
Schweitzer, R ;
Sun, DQ ;
Kaghad, M ;
Walker, N ;
Bronson, RT ;
Tabin, C ;
Sharpe, A ;
Caput, D ;
Crum, C ;
McKeon, F .
NATURE, 1999, 398 (6729) :714-718
[47]   p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities [J].
Yang, AN ;
Kaghad, M ;
Wang, YM ;
Gillett, E ;
Fleming, MD ;
Dotsch, V ;
Andrews, NC ;
Caput, D ;
McKeon, F .
MOLECULAR CELL, 1998, 2 (03) :305-316
[48]   A COMPARISON OF THE BIOLOGICAL-ACTIVITIES OF WILD-TYPE AND MUTANT-P53 [J].
ZAMBETTI, GP ;
LEVINE, AJ .
FASEB JOURNAL, 1993, 7 (10) :855-865
[49]   POLYMORPHISM AT CODON-72 OF THE P53 GENE IN HUMAN ACUTE MYELOGENOUS LEUKEMIA [J].
ZHANG, W ;
HU, GY ;
DEISSEROTH, A .
GENE, 1992, 117 (02) :271-275